131 related articles for article (PubMed ID: 7862945)
1. Nonlinear relationship between circulating concentrations of reduced haloperidol and haloperidol: evaluation of possible mechanisms.
Eyles DW; Stedman TJ; Pond SM
Psychopharmacology (Berl); 1994 Oct; 116(2):161-6. PubMed ID: 7862945
[TBL] [Abstract][Full Text] [Related]
2. In vitro characterization of the oxidation of a pyridinium metabolite of haloperidol by human placenta: the effect of smoking.
Fang J; Song J
J Pharm Pharm Sci; 2012; 15(4):538-47. PubMed ID: 23106957
[TBL] [Abstract][Full Text] [Related]
3. Stereospecific reduction of haloperidol in human tissues.
Eyles DW; Pond SM
Biochem Pharmacol; 1992 Sep; 44(5):867-71. PubMed ID: 1530656
[TBL] [Abstract][Full Text] [Related]
4. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
[TBL] [Abstract][Full Text] [Related]
5. Disposition of haloperidol pyridinium and reduced haloperidol pyridinium in schizophrenic patients: no relationship with clinical variables during short-term treatment.
Ulrich S; Neuhof S; Braun V; Danos P; Pester U; Hoy L
J Clin Psychopharmacol; 2000 Apr; 20(2):210-9. PubMed ID: 10770460
[TBL] [Abstract][Full Text] [Related]
6. Chirality of reduced haloperidol in humans.
Eyles DW; McGrath JJ; Stedman TJ; Pond SM
Eur Neuropsychopharmacol; 1998 May; 8(2):127-9. PubMed ID: 9619691
[TBL] [Abstract][Full Text] [Related]
7. Trace analysis of haloperidol and its chiral metabolite in plasma by capillary electrophoresis.
Wu SM; Ko WK; Wu HL; Chen SH
J Chromatogr A; 1999 Jun; 846(1-2):239-43. PubMed ID: 10420615
[TBL] [Abstract][Full Text] [Related]
8. Determination of haloperidol and reduced haloperidol in human serum by liquid chromatography after fluorescence labeling based on the Suzuki coupling reaction.
Kishikawa N; Hamachi C; Imamura Y; Ohba Y; Nakashima K; Tagawa Y; Kuroda N
Anal Bioanal Chem; 2006 Oct; 386(3):719-24. PubMed ID: 16957915
[TBL] [Abstract][Full Text] [Related]
9. The measurement of haloperidol and reduced haloperidol in neonatal hair as an index of placental transfer of maternal haloperidol.
Uematsu T; Yamada K; Matsuno H; Nakashima M
Ther Drug Monit; 1991 Mar; 13(2):183-7. PubMed ID: 2053128
[TBL] [Abstract][Full Text] [Related]
10. Ketone reductase activity and reduced haloperidol/haloperidol ratios in haloperidol-treated schizophrenic patients.
Huang HF; Jann MW; Tseng YT; Chung MC; Chien CP; Chang WH
Psychiatry Res; 1995 Jul; 57(2):101-8. PubMed ID: 7480377
[TBL] [Abstract][Full Text] [Related]
11. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients.
Ulrich S; Sandmann U; Genz A
Pharmacopsychiatry; 2005 Jul; 38(4):171-7. PubMed ID: 16025420
[TBL] [Abstract][Full Text] [Related]
12. Determination of haloperidol and reduced haloperidol in the plasma and blood of patients on depot haloperidol.
Eyles DW; Whiteford HA; Stedman TJ; Pond SM
Psychopharmacology (Berl); 1992; 106(2):268-74. PubMed ID: 1549652
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
Avent KM; DeVoss JJ; Gillam EM
Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
[TBL] [Abstract][Full Text] [Related]
14. Asymmetric redox reactions in human liver stereoselective oxidation of optically active dihydrohaloperidols, dihydrobromoperidols and stereospecific reduction of haloperidol and bromoperidol.
Takeshita M; Miura M; Ohkubo T; Sugawara K
Enantiomer; 2000; 5(2):189-95. PubMed ID: 10857058
[TBL] [Abstract][Full Text] [Related]
15. In vitro characterization of the metabolism of haloperidol using recombinant cytochrome p450 enzymes and human liver microsomes.
Fang J; McKay G; Song J; Remillrd A; Li X; Midha K
Drug Metab Dispos; 2001 Dec; 29(12):1638-43. PubMed ID: 11717183
[TBL] [Abstract][Full Text] [Related]
16. Formation of pyridinium species of haloperidol in human liver and brain.
Eyles DW; McGrath JJ; Pond SM
Psychopharmacology (Berl); 1996 Jun; 125(3):214-9. PubMed ID: 8815956
[TBL] [Abstract][Full Text] [Related]
17. Relation of plasma and red blood cells reduced haloperidol concentrations to haloperidol reductase activity assayed in red blood cells in psychiatric population.
Shibasaki M; Someya T; Takahashi S
Prog Neuropsychopharmacol Biol Psychiatry; 1993 Mar; 17(2):257-67. PubMed ID: 8430218
[TBL] [Abstract][Full Text] [Related]
18. Studies on the metabolism of haloperidol (HP): the role of CYP3A in the production of the neurotoxic pyridinium metabolite HPP+ found in rat brain following ip administration of HP.
Igarashi K; Kasuya F; Fukui M; Usuki E; Castagnoli N
Life Sci; 1995 Nov; 57(26):2439-46. PubMed ID: 8847965
[TBL] [Abstract][Full Text] [Related]
19. Haloperidol reductase in human and guinea pig livers.
Inaba T; Kovacs J
Drug Metab Dispos; 1989; 17(3):330-3. PubMed ID: 2568916
[TBL] [Abstract][Full Text] [Related]
20. Haloperidol reduction can be assayed in human red blood cells.
Inaba T; Kalow W; Someya T; Takahashi S; Cheung SW; Tang SW
Can J Physiol Pharmacol; 1989 Nov; 67(11):1468-9. PubMed ID: 2697459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
